Skinvisible, Inc. (SKVI) stock
SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026Market cap $843.54KP/E –Yield –
Skinvisible EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Skinvisible's EV/EBITDA was 1.7× on Jan 31, 2023, against 9.4× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 1.7× | +0.1 |
| 2022 | Dec 30, 2022 | 1.6× | −13.4 |
| 2021 | Dec 31, 2021 | 15.0× | – |
See a number that looks wrong?